With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Pediatric Oncology Nurses' Experiences with Prognosis-Related Communication||Marquette University / Amy Newman, RN, MSN||Nurse Researcher Grants||2014||Wisconsin|
|Perinatal Hormonal Biomarkers and Risk of Testicular Germ Cell Tumors||University of California Berkeley / Catherine Metayer, MD, PhD||Epidemiology Grants||2014||California|
|Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors||Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Georgia|
|Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma||Dana-Farber Cancer Institute / Thomas Look, M.D.||Innovation Grants||2014||Massachusetts|
|Serious Morbidity and Financial Outcomes Among Pediatric Cancer Survivors||Fred Hutchinson Cancer Research Center / Beth Mueller, PhD||Epidemiology Grants||2014||Washington|
|SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia||Dana-Farber Cancer Institute / Brenton Mar, MD, PhD||Young Investigator Grants||2014||Massachusetts|
|STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML||Baylor College of Medicine / Michele Redell, M.D./Ph.D.||Springboard Grants||2014||Texas|
|Symptom Patterns during Pediatric Hematopoietic Stem Cell Transplant Recovery||Duke University Medical Center / Cheryl Rodgers, RN, PhD||Nurse Researcher Grants||2014||North Carolina|
|Targeted Inhibition of the DNA Damage Response Pathway: A Novel Intervention in the Treatment of Pediatric Leukemias||National Cancer Institute / Andre Nussenzweig, Ph.D.||Reach Grants||2014||Maryland|
|Targeted Therapy for Core Binding Factor Leukemia||University of Massachusetts Medical School / John Pulikkan, PhD||Young Investigator Grants||2014||Massachusetts|